SJS Investment Consulting’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57K | Sell |
20
-40
| -67% | -$3.13K | ﹤0.01% | 648 |
|
|
2025
Q1 | $4.35K | Buy |
60
+5
| +9% | +$362 | ﹤0.01% | 491 |
|
|
2024
Q4 | $4.07K | Buy |
55
+34
| +162% | +$2.52K | ﹤0.01% | 471 |
|
|
2024
Q3 | $1.39K | Buy |
21
+9
| +75% | +$594 | ﹤0.01% | 949 |
|
|
2024
Q2 | $1.11K | Hold |
12
| – | – | ﹤0.01% | 989 |
|
|
2024
Q1 | $1.15K | Buy |
12
+1
| +9% | +$96 | ﹤0.01% | 987 |
|
|
2023
Q4 | $839 | Hold |
11
| – | – | ﹤0.01% | 1026 |
|
|
2023
Q3 | $763 | Sell |
11
-1
| -8% | -$69 | ﹤0.01% | 1042 |
|
|
2023
Q2 | $1.13K | Sell |
12
-19
| -61% | -$1.79K | ﹤0.01% | 849 |
|
|
2023
Q1 | $2.57K | Sell |
31
-1
| -3% | -$83 | ﹤0.01% | 527 |
|
|
2022
Q4 | $2.39K | Buy |
32
+6
| +23% | +$448 | ﹤0.01% | 552 |
|
|
2022
Q3 | $2K | Buy |
+26
| New | +$2K | ﹤0.01% | 456 |
|
|
2022
Q1 | $46K | Buy |
392
+199
| +103% | +$23.4K | 0.01% | 186 |
|
|
2021
Q4 | $25K | Buy |
+193
| New | +$25K | 0.01% | 242 |
|